Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases (Q31100823)

28 June 2017

0 references

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases (English)

1 reference

28 June 2017

1 reference

cardiovascular disease

1 reference

S Robins

40

0 references

Dietrich Rothenbacher

D Rothenbacher

19

0 references

Philippa Talmud

P Talmud

28

0 references

Emmanouil S. Brilakis

E Brilakis

23

0 references

Albert Hofman

33

51

A Hofman

1 reference

28 June 2017

18

H Brenner

1 reference

28 June 2017

Elizabeth Barrett-Connor

32

E Barrett-Connor

1 reference

28 June 2017

21

M Persson

1 reference

28 June 2017

6

K T Khaw

1 reference

28 June 2017

17

W Koenig

1 reference

28 June 2017

25

W Koenig

1 reference

28 June 2017

Jacqueline C M Witteman

35

J C M Witteman

1 reference

28 June 2017

16

J Anderson

1 reference

28 June 2017

15

R Collins

1 reference

28 June 2017

45

P Ridker

1 reference

28 June 2017

Lp-PLA2 Studies Collaboration

1

1 reference

28 June 2017

C Ballantyne

2

1 reference

28 June 2017

M Cushman

3

1 reference

28 June 2017

C Furberg

5

1 reference

28 June 2017

M Sandhu

7

1 reference

28 June 2017

J Oldgren

8

1 reference

28 June 2017

G P Rossi

9

1 reference

28 June 2017

G Maiolino

10

1 reference

28 June 2017

M Cesari

11

1 reference

28 June 2017

L Lenzini

12

1 reference

28 June 2017

S K James

13

1 reference

28 June 2017

E Rimm

14

1 reference

28 June 2017

G Berglund

20

1 reference

28 June 2017

P Berger

22

1 reference

28 June 2017

J P McConnell

24

1 reference

28 June 2017

R Sacco

26

1 reference

28 June 2017

M Elkind

27

1 reference

28 June 2017

E Rimm

29

1 reference

28 June 2017

C P Cannon

30

1 reference

28 June 2017

C Packard

31

1 reference

28 June 2017

I Kardys

34

1 reference

28 June 2017

M Criqui

36

1 reference

28 June 2017

J P Corsetti

37

1 reference

28 June 2017

D L Rainwater

38

1 reference

28 June 2017

A J Moss

39

1 reference

28 June 2017

H Bloomfield

41

1 reference

28 June 2017

D Collins

42

1 reference

28 June 2017

C Packard

43

1 reference

28 June 2017

S Wassertheil-Smoller

44

1 reference

28 June 2017

C Ballantyne

46

1 reference

28 June 2017

C P Cannon

47

1 reference

28 June 2017

M Cushman

48

1 reference

28 June 2017

J Danesh

49

1 reference

28 June 2017

D Gu

50

1 reference

28 June 2017

J J Nelson

52

1 reference

28 June 2017

S Thompson

53

1 reference

28 June 2017

A Zalewski

54

1 reference

28 June 2017

N Zariffa

55

1 reference

28 June 2017

E Di Angelantonio

56

1 reference

28 June 2017

S Kaptoge

57

1 reference

28 June 2017

A Thompson

58

1 reference

28 June 2017

S Thompson

59

1 reference

28 June 2017

M Walker

60

1 reference

28 June 2017

S Watson

61

1 reference

28 June 2017

A Wood

62

1 reference

28 June 2017

B Psaty

4

1 reference

28 June 2017

1 February 2007

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

28 June 2017

1 reference

28 June 2017

14

1 reference

28 June 2017

3-11

1 reference

28 June 2017

1

1 reference

Phospholipase A2 and small, dense low-density lipoprotein

28 June 2017

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infar

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Prediction of the risk of myocardial infarction from polymorphisms in candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Multinomial regression models based on continuation ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000239464.18509.F1

10.1097/01.HJR.0000239464.18509.F1

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference